6 Dimensions Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
24
- Investments
-
86
- Portfolio
-
45
- Exits
-
24
6 Dimensions Capital General Information
Description
6 Dimensions Capital is a healthcare investment firm that focuses on the investments of healthcare startups or growth stage companies with operations in the U.S., Europe, China, Israel and other countries. It helps and enables entrepreneurs to create and grow innovative healthcare businesses for the benefits of patients worldwide. It was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The firm is headquartered in Shanghai, China with offices in Boston, San Francisco and Hong Kong.
Contact Information
Website
www.6dimensionscapital.com
Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- Block 17, No.999 Huanke Road
- Pudong New District Post:201210
- Shanghai
- China
+86 021 0000 0000
6 Dimensions Capital Investments & Acquisitions (86)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| M6P Therapeutics | 01-Sep-2022 | Later Stage VC | Biotechnology | Generating Revenue | ||
| 0-000 000000000000 | 05-Aug-2022 | 00000 00000 | Drug Discovery | Generating Revenue | ||
| 00000000 | 01-Mar-2022 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue | 000 00 00.0 |
| 00000 000000000000 | 11-Nov-2021 | 00000 00000 | 00000 | Drug Discovery | Startup | |
| 00000000000 | 01-Nov-2021 | 00000 00000 | 000.00 | Diagnostic Equipment | Generating Revenue | |
| 0000000 000000 | 01-Nov-2021 | 00000 00000 | 000.00 | Therapeutic Devices | Generating Revenue | |
| 000 000000000000 | 04-Oct-2021 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | |
| 0000000000 | 06-Sep-2021 | 00000 00000 | 000.00 | Clinics/Outpatient Services | Generating Revenue | |
| Nanos Medical | 01-Jul-2021 | Later Stage VC | Medical Supplies | Generating Revenue | ||
| Engine Biosciences | 26-May-2021 | Later Stage VC | 0000 | Biotechnology | Generating Revenue | 00000000 0000 00.0 |
6 Dimensions Capital Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| JC Medical | 04-Feb-2022 | Merger/Acquisition | |
| 00000 | 18-Aug-2021 | 000000000000000000 | 00.00 |
| 0000000 | 06-Aug-2021 | 000 00 00000000 | |
| 00000 000000000000 | 16-Jul-2021 | 000 | 00000 |
| 0000 00000000000 | 13-Jul-2021 | 000 | 00000 |
| 00000 000 | 15-Mar-2021 | 000000000000000000 | 000 |
| 0000 000000000000 | 21-Jan-2021 | 000000 0000000000 | 00000 |
| 0000000 | 08-Jan-2021 | 000 | 00000 |
| Kymera Therapeutics | 21-Aug-2020 | IPO | 00000 |
| TCR2 Therapeutics | 29-Jul-2020 | Public Investment 2nd Offering | 00000 |
6 Dimensions Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
6 Dimensions Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
6 Dimensions Capital Team (25)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Lianyong Chen Ph.D | Co-Founding Partner & Chief Executive Officer | 00 | 0 | 0 | Shanghai, China |
| Christina Chung | Chief Financial Officer | Shanghai, China | |||
| Colin Wang Ph.D | Managing Director | Shanghai, China | |||
| Wei Li Ph.D | Co-Founding Partner & Managing Partner | 00 | 0 | 0 | Shanghai, China |
| Ching Zhu Ph.D | Managing Partner & Member of Investment & Management Team | 0 | 0 | 0 | Shanghai, China |
6 Dimensions Capital Co-Investors (116)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 4 | 0 |
|
|
|
| HBM Healthcare Investments | 0 | 0 |
|
|
|
| RA Capital Management | 0 | 0 |
|
|
|
| The Invus Group | 0 | 0 |
|
|
|
| HBM Partners | 0 | 0 |
|
|